Sort
50,496 grants matching “lung cancer”
Inherited genetic risk factors common to COPD and lung cancer.
$465,981James C Willey · University Of Toledo Health Sci Campus · R01 · FY2013 · HL
Epigenetic Stress and Chromate Carcinogenesis
$465,979Max Costa · New York University School Of Medicine · R01 · FY2021 · ES
Radiologist-Centered Artificial Intelligence (RCAI) for Lung Cancer Screening and Diagnosis
$465,969Ulas Bagci · Northwestern University At Chicago · R01 · FY2024 · CA
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis
$465,922Rhonda Szczesniak · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · HL
Clinical Diagnostic Studies and Treatment of Patients with Immune Deficiencies
$465,906Suk De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$465,896Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Chemoenzymatic methods for the detection of cellsurface glycans
$465,892Peng Wu · Scripps Research Institute, The · R01 · FY2018 · GM
Chemoenzymatic methods for the detection of cellsurface glycans
$465,890Peng Wu · Scripps Research Institute, The · R01 · FY2017 · GM
Identifying Therapeutic Targets for Stage III Melanoma
$465,890Anand K Ganesan · University Of California-Irvine · R01 · FY2021 · CA
Deguelin in therapy of triple negative breast cancer
$465,889Rajendra G Mehta · Iit Research Institute · R01 · FY2012 · CA
Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
$465,839Duke University · U01 · FY2004 · CA
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
$465,818Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2019 · CA
A mechanism-based computational tool to optimize pulmonary drug delivery
$465,646Andrzej J Przekwas · Cfd Research Corporation · R44 · FY2017 · GM
EGFR Mutations in Non-Small Cell Lung Cancer
$465,626Bruce E. Johnson · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$465,623Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · CA
Inherited genetic risk factors common to COPD and lung cancer.
$465,613James C Willey · University Of Toledo Health Sci Campus · R01 · FY2012 · HL
QSTAR Elite Quadrupole-o-TOF LC/MS/MS System
$465,600Bradford Wayne Gibson · Buck Institute For Research On Aging · S10 · FY2007 · RR
Targeting replication stress signaling to overcome immune evasion in small cell lung cancer
$465,558Triparna Sen · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Targeted Inhibition in Leukemia
$465,554Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
CHRYSOTILE AND LUNG CANCER: TIME-RELATED EFFECTS AND POOLED ANALYSIS
$465,548Dana P Loomis · University Of Nevada Reno · R01 · FY2008 · OH
Heparan Sulfate--a Novel Target for Cancer Therapeutics
$465,503University Of California San Diego · U01 · FY2003 · CA
Interdisciplinary Training Program in Lung Disease
$465,489Claude A Piantadosi · Duke University · T32 · FY2018 · HL
HVEM-BTLA system in inflammation
$465,485Carl F Ware · La Jolla Institute For Immunology · R01 · FY2008 · AI
HVEM-BTLA system in inflammation
$465,485Carl F Ware · La Jolla Institute For Immunology · R01 · FY2009 · AI
SRC-3/PELP1 complexes drive stem-like phenotypes in luminal breast cancer
$465,438Carol Ann Lange · University Of Minnesota · R01 · FY2024 · CA